Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:administered_by |
gptkb:tablet
gptkb:Sugar |
| gptkbp:available_on |
gptkb:pharmaceuticals
generic medication brand name medication |
| gptkbp:can_be_used_with |
gptkb:ibuprofen
gptkb:acetaminophen aspirin |
| gptkbp:chemical_formula |
C18 H21 NO3
|
| gptkbp:developed_by |
opium
|
| https://www.w3.org/2000/01/rdf-schema#label |
Codeine
|
| gptkbp:ingredients |
physicians
|
| gptkbp:is_associated_with |
tolerance
withdrawal symptoms dependence addiction risk overdose risk |
| gptkbp:is_available_in |
liquid form
tablet form injection form |
| gptkbp:is_available_over_the_counter |
in some formulations
|
| gptkbp:is_controlled_substance |
Schedule II (in some formulations)
Schedule III (in some formulations) |
| gptkbp:is_involved_in |
clinical trials
|
| gptkbp:is_known_for |
its analgesic properties
its sedative effects its antitussive properties |
| gptkbp:is_metabolized_to |
morphine
|
| gptkbp:is_part_of |
combination therapies
WHO Model List of Essential Medicines multimodal analgesia cough treatment protocols pain management protocols cough management guidelines pain relief guidelines |
| gptkbp:is_related_to |
oxycodone
hydrocodone |
| gptkbp:is_studied_for |
pain management efficacy
cough suppression efficacy |
| gptkbp:is_subject_to |
gptkb:regulations
monitoring |
| gptkbp:is_used_for |
pain relief
cough suppression |
| gptkbp:is_used_in |
gptkb:cancer_treatment
hospital settings palliative care emergency medicine chronic pain management outpatient settings post-operative pain management pediatric medicine (with caution) |
| gptkbp:legal_status |
many countries
|
| gptkbp:reported_by |
some countries
|
| gptkbp:side_effect |
nausea
drowsiness constipation |
| gptkbp:suitable_for |
children under 12
breastfeeding mothers people with respiratory issues |
| gptkbp:bfsParent |
gptkb:Chris_Brokaw
|
| gptkbp:bfsLayer |
6
|